^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

IL4 elevation

i
Other names: IL4, Interleukin 4, Lymphocyte Stimulatory Factor 1, IL-4, B_cell Stimulatory Factor 1, B Cell Growth Factor 1, Interleukin-4, Binetrakin, Pitrakinra, BCGF-1, BCGF1, BSF-1, BSF1, B-Cell Stimulatory Factor 1, Interleukin 4 Variant, MGC79402
Entrez ID:
1year
Investigation of potential anti-metastatic effect of metformin and caffeic acid combination therapy in breast cancer cell line in in-vitro culture model. (PubMed, Med Oncol)
RT-qPCR results largely supported the ELISA findings. Overall, CA and MTF exhibited potential to inhibit MCF-7 cell apoptosis, migration, tumor microenvironment modulation, and metastasis.
Preclinical • Journal
|
CDH1 (Cadherin 1) • IL1B (Interleukin 1, beta) • IL4 (Interleukin 4)
|
IL4 elevation
|
metformin
1year
Protective Effect of Platycodin D on Allergic Rhinitis in Mice through DPP4/JAK2/STAT3 Pathway Inhibition. (PubMed, Curr Mol Pharmacol)
The findings suggested the potential of PLD as a therapeutic agent for the treatment of AR.
Preclinical • Journal
|
JAK2 (Janus kinase 2) • IFNG (Interferon, gamma) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • STAT3 (Signal Transducer And Activator Of Transcription 3) • IL13 (Interleukin 13) • IL1B (Interleukin 1, beta) • IL4 (Interleukin 4)
|
IL4 elevation • IL6 expression
1year
Heart Rate Variability and Cytokines are Involved in Anxiety in Breast Cancer Patients: A Cross-Sectional Study. (PubMed, Clin Breast Cancer)
Our results indicate that BC patients with low HRV are associated with higher levels of inflammation and anxiety. Therefore, the measurement of HRV may serve as an objective and non-invasive measurement method for monitoring the immune system and anxiety problems of BC patients.
Observational data • Journal
|
IFNG (Interferon, gamma) • IL6 (Interleukin 6) • IL4 (Interleukin 4)
|
IL4 elevation
1year
Adiponectin, resistin, interleukin-4 and TGF-β2 levels in treatment resistant schizophrenia patients. (PubMed, Prog Neuropsychopharmacol Biol Psychiatry)
We report elevated resistin and IL-4 levels and decreased adiponectin levels in first-episode, treatment resistant schizophrenia patients after clozapine treatment. These findings may be at least partly due to the anti-inflammatory action of clozapine, although sub-clinical metabolic disturbances may also have played a role as far as resistin and adiponectin are concerned. In a subgroup of these patients we report reduced TGF-β2 and adiponectin levels after two unsuccessful trials with risperidone and olanzapine comparing them with the ones of the same subgroup in the drug-naïve phase.
Journal
|
TGFB1 (Transforming Growth Factor Beta 1) • IL4 (Interleukin 4)
|
IL4 elevation
|
olanzapine
1year
Severe interstitial lung disease risk prediction in anti-melanoma differentiation-associated protein 5 positive dermatomyositis: the STRAD-Ro52 model. (PubMed, Ann Med)
Multifactorial regression of clinical indicators showed that the presence of anti-Ro52 antibodies was an independent risk factor for severe ILD, leading to the establishment of the STRAD-Ro52 model. The STRAD-Ro52 model assists in identifying MDA5+DM patients at risk of developing severe ILD within six months, further optimizing precise disease management and clinical research design.
Retrospective data • Journal
|
IFIH1 (Interferon Induced With Helicase C Domain 1) • IL4 (Interleukin 4)
|
IL4 elevation
1year
Fetuin-A as a plausible biomarker for cardiac valve calcification in rheumatic heart disease patients from North India. (PubMed, Asian Cardiovasc Thorac Ann)
This study suggests that fetuin-A can be explored as a plausible biomarker for cardiac valve calcification and has an inverse correlation with inflammatory cytokines involved in RHD.
Journal
|
IFNG (Interferon, gamma) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL17A (Interleukin 17A) • IL4 (Interleukin 4) • AHSG (Alpha 2-HS Glycoprotein)
|
IL4 elevation
1year
Study on the therapeutic effect and some immune factors by methotrexate modified superparamagnetic nanoparticles in rat mammary tumors. (PubMed, Nanoscale Adv)
They are safe, tolerable, contribute to prolonged survival, and enhance immune functions in tumor-bearing rats without leaving residues in vital organs. These results provide a promising foundation for future cancer treatment research.
Preclinical • Journal
|
IFNG (Interferon, gamma) • IL2 (Interleukin 2) • IL4 (Interleukin 4)
|
IL4 elevation
|
methotrexate
1year
LIPCAL-ALS II: Ultra-high-caloric, Fatty Diet in ALS (clinicaltrials.gov)
P=N/A, N=392, Recruiting, University of Ulm | Not yet recruiting --> Recruiting
Enrollment open
|
BAP1 (BRCA1 Associated Protein 1) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • CHI3L1 (Chitinase 3-like 1) • CCL2 (Chemokine (C-C motif) ligand 2) • GPNMB (Glycoprotein Nmb) • IL17A (Interleukin 17A) • IL1B (Interleukin 1, beta) • IL4 (Interleukin 4) • GFAP (Glial Fibrillary Acidic Protein)
|
IL4 elevation
1year
Impacts of mesenchymal stem cells and hyaluronic acid on inflammatory indicators and antioxidant defense in experimental ankle osteoarthritis. (PubMed, World J Orthop)
BMMSCs and/or HA have anti-arthritic effects mediated by antioxidant and anti-inflammatory effects on MIA-induced OA. MMP-13 and TGF-β1 expression improves BMMSCs and/or HA effects on OA in Wistar rats.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • CD34 (CD34 molecule) • PTPRC (Protein Tyrosine Phosphatase Receptor Type C) • TGFB1 (Transforming Growth Factor Beta 1) • IL17A (Interleukin 17A) • THY1 (Thy-1 membrane glycoprotein) • ENG (Endoglin) • IL4 (Interleukin 4)
|
IL4 elevation
over1year
HMB: Precision Medicine and Physical Function (clinicaltrials.gov)
P=N/A, N=25, Recruiting, University of North Carolina, Chapel Hill | Trial completion date: Jun 2024 --> Jun 2025 | Trial primary completion date: Jun 2024 --> Jun 2025
Trial completion date • Trial primary completion date
|
CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL17A (Interleukin 17A) • IL13 (Interleukin 13) • IL4 (Interleukin 4) • IL5 (Interleukin 5)
|
IL10 elevation • IL13 elevation • IL4 elevation
over1year
Effect of Epstein-Barr virus on macrophage M2/M1 migration and EphA2 expression in adverse drug reactions. (PubMed, J Dermatol)
This study aims to investigate the effect of Epstein-Barr virus (EBV) reactivation or EBV reactivation with dexamethasone (DXM) in patients with adverse drug reactions (ADRs) through evaluating the levels of monocyte, macrophage M2/M1, and cytokines, and investigating whether expression of EBV receptor EphA2 could specifically influence EBV activation in ADRs...The elevation in EPhA2 correlated with increased EBV viral load, particularly in MPE and SJS/TEN patients, suggesting that adverse drug reactions may induce EPhA2 expression, facilitating EBV replication and activation. EphA2 could thus serve as an indicator of EBV activation and a marker for assessing the risk of EBV in patients with adverse drug reactions.
Journal • Adverse drug reaction
|
IFNG (Interferon, gamma) • TNFA (Tumor Necrosis Factor-Alpha) • CXCL10 (Chemokine (C-X-C motif) ligand 10) • CXCL9 (Chemokine (C-X-C motif) ligand 9) • EPHA2 (EPH receptor A2) • IL13 (Interleukin 13) • IL4 (Interleukin 4) • IFNB1 (Interferon Beta 1)
|
IL4 elevation
|
dexamethasone
over1year
Individuals Who Had a Lifetime History of Suicide Attempts and Their Relationships With Inflammation, Severity of Depressive Symptoms, and Childhood Maltreatments. (PubMed, J Nerv Ment Dis)
IL-4 levels were significantly lower in individuals who attempted suicide than in nonsuicidal individuals. Lifetime suicide attempts in major affective disorders were associated with childhood trauma and proinflammatory and anti-inflammatory cytokines.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • IL4 (Interleukin 4)
|
IL4 elevation